Information Provided By: 
Fly News Breaks for July 7, 2016
NVDQ
Jul 7, 2016 | 07:51 EDT
Canaccord analyst Jason Mills recommends adding to Novadaq positions amid the weakness seen in the stock following the CEO transition news, saying that while Dr. Menawat's exit was "abrupt" and a surprise, his departure was not performance-related nor due to a material concern about the company's long-term health. Mills, who believes Novadaq is set up for 30%-35% growth over the medium-term and remains bullish about the company over the long term, keeps a Buy rating and $15 price target on the stock.
News For NVDQ From the Last 2 Days
There are no results for your query NVDQ
